Target intelligence / Profile preview

Tetraspanin-31 (TSPAN31)

Target
TSPAN31
Molecular classification
Tetraspanin family, Transmembrane 4 superfamily, Cell-surface protein
01

Overview

Tetraspanin-31 is a cell-surface transmembrane protein with four hydrophobic domains, belonging to the tetraspanin family, and is involved in numerous cellular processes such as signal transduction, proliferation, migration, and survival. It plays important roles in cancer biology, including osteosarcoma, gastric cancer, and hepatocellular carcinoma, by promoting tumor growth, motility, and suppressing apoptosis. TSPAN31 is also implicated in regulating key signaling pathways (e.g., AKT/GSK-3β/β-catenin, PI3K/Akt), and its increased expression is associated with aggressive tumor behavior and poor patient outcomes[1][2][3][4]. No approved drugs specifically target TSPAN31 yet, but its biomarker potential and mechanistic relevance in cancer make it an attractive target for ongoing research.

Other names
TSPAN31SAS (Sarcoma-amplified sequence)Tspan-31Sarcoma-amplified sequenceTransmembrane 4 proteintspan-31
02

Mechanism of action

Inhibition of TSPAN31 or its gene silencing can suppress tumor cell proliferation, migration, and invasion, and induce apoptosis, likely through disruption of signaling pathways such as PI3K/Akt and the AKT/GSK-3β/β-catenin axis[2][3].

03

Biological functions

Signal transductionRegulation of cell developmentCell activationCell growthCell motilityCell survivalApoptosisCell proliferationCell migration
04

Disease associations

Cancer (with significant roles in osteosarcoma, hepatocellular carcinoma, and gastric cancer)TumorigenesisCancer progression and metastasis
05

Safety considerations

Safety concerns are undefined due to the absence of clinical-stage drugs. Therapeutic challenges include targeting membrane proteins implicated in multiple cellular processes, which may risk off-target effects and systemic toxicity[4].
06

Biomarkers

TSPAN31 expression correlates with poor prognosis and tumor invasion in gastric and liver cancers, making it a candidate biomarker for disease progression and recurrence[3].

Beyond the preview

Go deeper on Tetraspanin-31 (TSPAN31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetraspanin-31 (TSPAN31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call